POZEN to Host Analyst and Investor Update Webcast

POZEN to Host Analyst and Investor Update Webcast 
CHAPEL HILL, NC -- (Marketwired) -- 04/09/13 --   POZEN Inc. (NASDAQ:
POZN), a pharmaceutical company committed to transforming medicine
that transforms lives, today announced that it will hold an Analyst
and Investor Update webcast Thursday, April 18, 2013 from 10:00 a.m.
- 11:30 a.m. (EDT). During the webcast, management will provide an
update for POZEN's PA program and two outside experts will discuss
thoughts on the use of aspirin in the cardiovascular space and the
reimbursement landscape. The live webcast and replay will be
available at www.pozen.com.  
About POZEN 
POZEN Inc. is a small pharmaceutical company that specializes in
developing novel therapeutics for unmet medical needs and licensing
those products to other pharmaceutical companies for
commercialization. By utilizing a unique in-source model and focusing
on integrated therapies, POZEN has successfully developed and
obtained FDA approval of two self-invented products in two years.
Funded by these milestones/royalty streams, POZEN is creating a
portfolio of cost-effective, evidence-based integrated aspirin
therapies designed to enable the full power of aspirin by reducing
its GI damage.  
POZEN is currently seeking strategic partners to help maximize the
opportunities for its portfolio assets. 
The Company's common stock is traded under the symbol "POZN" on The
NASDAQ Global Market. For more detailed company information,
including copies of this and other press releases, please visit
www.pozen.com.  
FOR FURTHER INFORMATION:
Bill Hodges
Chief Financial Officer
(919) 913-1030 
Stephanie Bonestell
Manager, Investor Relations & Public Relations
(919) 913-1030 
 
 
Press spacebar to pause and continue. Press esc to stop.